APA (7th ed.) Citation

de Porto, A. P., Liu, Z., de Beer, R., Florquin, S., de Boer, O. J., Hendriks, R. W., . . . de Vos, A. F. (2019). Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia. Molecular medicine (Cambridge, Mass.), 25(1), 3-10. https://doi.org/10.1186/s10020-018-0069-7

Chicago Style (17th ed.) Citation

de Porto, Alexander P., Zhe Liu, Regina de Beer, Sandrine Florquin, Onno J. de Boer, Rudi W. Hendriks, Tom van der Poll, and Alex F. de Vos. "Btk Inhibitor Ibrutinib Reduces Inflammatory Myeloid Cell Responses in the Lung During Murine Pneumococcal Pneumonia." Molecular Medicine (Cambridge, Mass.) 25, no. 1 (2019): 3-10. https://doi.org/10.1186/s10020-018-0069-7.

MLA (9th ed.) Citation

de Porto, Alexander P., et al. "Btk Inhibitor Ibrutinib Reduces Inflammatory Myeloid Cell Responses in the Lung During Murine Pneumococcal Pneumonia." Molecular Medicine (Cambridge, Mass.), vol. 25, no. 1, 2019, pp. 3-10, https://doi.org/10.1186/s10020-018-0069-7.